Cargando…

Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Boza-Serrano, Antonio, Ruiz, Rocío, Sanchez-Varo, Raquel, García-Revilla, Juan, Yang, Yiyi, Jimenez-Ferrer, Itzia, Paulus, Agnes, Wennström, Malin, Vilalta, Anna, Allendorf, David, Davila, Jose Carlos, Stegmayr, John, Jiménez, Sebastian, Roca-Ceballos, Maria A., Navarro-Garrido, Victoria, Swanberg, Maria, Hsieh, Christine L., Real, Luis M., Englund, Elisabet, Linse, Sara, Leffler, Hakon, Nilsson, Ulf J., Brown, Guy C., Gutierrez, Antonia, Vitorica, Javier, Venero, Jose Luis, Deierborg, Tomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020311/ https://www.ncbi.nlm.nih.gov/pubmed/36790609 http://dx.doi.org/10.1007/s00401-023-02549-1

Ejemplares similares

Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
por: Boza-Serrano, Antonio, et al.
Publicado: (2019)

Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
por: Bachiller, Sara, et al.
Publicado: (2018)

Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
por: Garcia-Revilla, Juan, et al.
Publicado: (2020)

The role of Galectin-3 in α-synuclein-induced microglial activation
por: Boza-Serrano, Antonio, et al.
Publicado: (2014)

Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson’s Disease
por: Jewett, Michael, et al.
Publicado: (2017)

Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
por: Boza-Serrano, Antonio, et al.
Publicado: (2022)

Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer’s disease mouse model 5xFAD
por: Boza-Serrano, Antonio, et al.
Publicado: (2018)

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration
por: García-Revilla, Juan, et al.
Publicado: (2022)

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
por: Fernández-Calle, Rosalía, et al.
Publicado: (2022)

The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement
por: Bachiller, Sara, et al.
Publicado: (2020)

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
por: García-Revilla, Juan, et al.
Publicado: (2023)

Glutathione S-Transferase Alpha 4 Prevents Dopamine Neurodegeneration in a Rat Alpha-Synuclein Model of Parkinson’s Disease
por: Jewett, Michael, et al.
Publicado: (2018)

Effective Knockdown of Gene Expression in Primary Microglia With siRNA and Magnetic Nanoparticles Without Cell Death or Inflammation
por: Carrillo-Jimenez, Alejandro, et al.
Publicado: (2018)

The Other Side of SARS-CoV-2 Infection: Neurological Sequelae in Patients
por: Alonso-Bellido, Isabel M., et al.
Publicado: (2021)

Who let the dogs out?: detrimental role of Galectin-3 in hypoperfusion-induced retinal degeneration
por: Manouchehrian, Oscar, et al.
Publicado: (2015)

Spatio-temporal activation of caspase-8 in myeloid cells upon ischemic stroke
por: Rodhe, Johanna, et al.
Publicado: (2016)

Inflammatory Animal Models of Parkinson’s Disease
por: García-Revilla, Juan, et al.
Publicado: (2022)

Inflammation leads to distinct populations of extracellular vesicles from microglia
por: Yang, Yiyi, et al.
Publicado: (2018)

Identification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson’s Disease
por: Kurowska, Zuzanna, et al.
Publicado: (2016)

Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease
por: Tayara, Khadija, et al.
Publicado: (2018)

Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration
por: Yip, Ping Kei, et al.
Publicado: (2017)

Function of TREM1 and TREM2 in Liver-Related Diseases
por: Sun, Huifang, et al.
Publicado: (2020)

Microglia in Alzheimer’s Disease: Activated, Dysfunctional or Degenerative
por: Navarro, Victoria, et al.
Publicado: (2018)

Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles
por: Jiménez, Mariela, et al.
Publicado: (2021)

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
por: Ashton, Nicholas J., et al.
Publicado: (2019)

Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases Aβ aggregation
por: Vilalta, Anna, et al.
Publicado: (2021)

The biology of TREM receptors
por: Colonna, Marco
Publicado: (2023)

sTREM-1 is a specific biomarker of TREM-1 pathway activation
por: Jolly, Lucie, et al.
Publicado: (2021)

TREM-1, TREM-2 and their association with disease severity in patients with COVID-19
por: Fan, Ruyue, et al.
Publicado: (2023)

Magnetofection as a new tool to study microglia biology
por: Venero, Jose Luis, et al.
Publicado: (2019)

Activated Microglia Desialylate and Phagocytose Cells via Neuraminidase, Galectin-3, and Mer Tyrosine Kinase
por: Nomura, Koji, et al.
Publicado: (2017)

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

TMEM59 interacts with TREM2 and modulates TREM2-dependent microglial activities
por: Liu, Zhaoji, et al.
Publicado: (2020)

TREM1 regulates antifungal immune responses in invasive pulmonary aspergillosis
por: Bernal-Martínez, L, et al.
Publicado: (2021)

Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus
por: Torres, Manuel, et al.
Publicado: (2012)

Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma
por: Ford, Jill W., et al.
Publicado: (2022)

Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson’s Disease
por: García-Domínguez, Irene, et al.
Publicado: (2018)

Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans
por: Stegmayr, John, et al.
Publicado: (2016)

Extracellular and intracellular small-molecule galectin-3 inhibitors
por: Stegmayr, John, et al.
Publicado: (2019)

TREM2 in Neurodegenerative Diseases
por: Jay, Taylor R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eqr2ji45atj6cb8qj56f42ohaf